Genfit Ownership
| GNFT Stock | USD 4.26 0.06 1.43% |
Shares in Circulation | First Issued 2012-09-30 | Previous Quarter 60.4 M | Current Value 60.4 M | Avarage Shares Outstanding 34.9 M | Quarterly Volatility 13 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Genfit |
Genfit Stock Ownership Analysis
The book value of the company was currently reported as 1.96. The company had not issued any dividends in recent years. Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France. Genfit SA operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 134 people. To learn more about Genfit call JeanFrancois Mouney at 33 3 20 16 40 00 or check out https://www.genfit.com.Besides selling stocks to institutional investors, Genfit also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Genfit's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Genfit's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Genfit Quarterly Liabilities And Stockholders Equity |
|
Genfit Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Genfit is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genfit backward and forwards among themselves. Genfit's institutional investor refers to the entity that pools money to purchase Genfit's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 65.5 K | Old Mission Capital Llc | 2024-06-30 | 12.8 K | Optiver Holding B.v. | 2024-06-30 | 2.2 K | Rhumbline Advisers | 2024-06-30 | 678 | Ubs Group Ag | 2024-06-30 | 346 | Advisor Group Holdings, Inc. | 2024-06-30 | 273 | Qube Research & Technologies | 2024-06-30 | 98.0 | Millennium Management Llc | 2024-06-30 | 0.0 |
Genfit Outstanding Bonds
Genfit issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genfit uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genfit bonds can be classified according to their maturity, which is the date when Genfit has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Genfit Corporate Filings
6K | 13th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 5th of April 2024 Other Reports | ViewVerify | |
13A | 14th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Genfit Stock Analysis
When running Genfit's price analysis, check to measure Genfit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genfit is operating at the current time. Most of Genfit's value examination focuses on studying past and present price action to predict the probability of Genfit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genfit's price. Additionally, you may evaluate how the addition of Genfit to your portfolios can decrease your overall portfolio volatility.